Evidence map›Paper›PMID 36837766›Full record

ArticleMetabolites2023

Effects of a Calorie-Restricted Cafeteria Diet and Oleuropein Supplementation on Adiposity and mRNA Expression of Energy Balance Related Genes in Obese Male Rats.

Alex Subias-Gusils, Adam Álvarez-Monell, Noemi Boqué, Antoni Caimari, Roger Mariné-Casadó, Rosa M Escorihuela, Montserrat Solanas

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Potential Therapeutic Properties ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alex Subias-GusilsInstitut de Neurociències, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.ORCID 0000-0001-6981-7383
Adam Álvarez-MonellInstitut de Neurociències, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.ORCID 0000-0003-4806-3361
Noemi BoquéEurecat, Centre Tecnològic de Catalunya, Biotechnology Area and Technological Unit of Nutrition and Health, 43204 Reus, Spain.ORCID 0000-0001-7173-5512
Antoni CaimariEurecat, Centre Tecnològic de Catalunya, Biotechnology Area and Technological Unit of Nutrition and Health, 43204 Reus, Spain.ORCID 0000-0001-6144-0294
Roger Mariné-CasadóEurecat, Centre Tecnològic de Catalunya, Biotechnology Area and Technological Unit of Nutrition and Health, 43204 Reus, Spain.ORCID 0000-0002-0924-4920
Rosa M EscorihuelaInstitut de Neurociències, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.ORCID 0000-0001-9368-5173
Montserrat SolanasInstitut de Neurociències, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.ORCID 0000-0003-2949-1344
Universitat Autònoma de Barcelona · ESTechnological Center of Nutrition and Health · ES

Funding

Catalan Government ACCIÓ-EURECATMinisterio de Ciencia e Innovación BES-2017-081939Spanish Ministerio de Economía, Indutria y Competitividad PSI2016-77234-RUniversitat Autònoma de Barcelona PIF-UAB2018
6 · The paper itself

Abstract

Supplementation with natural bioactive compounds has been proposed to be a complementary tool to the calorie-restricted diets and physical exercise programs used to tackle human overweight, obesity and Metabolic syndrome. Herein, we evaluated the effects of 14 weeks of calorie-restricted cafeteria diet either alone or combined with oral administration of the polyphenol oleuropein in obese adult male rats, compared with a control group fed standard chow and a group fed cafeteria diet. Animals were sacrificed at the age of 26 weeks and several tissues of interest were removed. The results showed that both dietary interventions reduced the adiposity index (

Indexed as

adiponectincalorie restrictiondietary supplementshypothalamusleptinmetabolic syndromewhite adipose tissue

Identifiers

PMID36837766
PMCPMC9965300
OpenAlexW4317426214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.